Table 1.
Baseline patient characteristics for those with an audio-recorded visit (N = 517)
|
Study group |
||||
|---|---|---|---|---|
|
Control |
Treatment |
|||
|
n = 261 |
n = 256 |
|||
| n | (%) | n | (%) | |
|
Age |
|
|
|
|
| < 50 |
56 |
21.5 |
96 |
37.5 |
| ≥ 50 |
205 |
78.5 |
160 |
62.5 |
| Median (range) |
59 |
(22–87) |
55 |
(22–86) |
|
Gender |
|
|
|
|
| Male |
142 |
54.4 |
123 |
48.0 |
| Female |
119 |
45.6 |
133 |
52.0 |
|
Clinical Service |
|
|
|
|
| Medical Oncology |
144 |
55.2 |
151 |
59.0 |
| Radiation Oncology |
87 |
33.3 |
86 |
33.6 |
| HSCT |
30 |
11.5 |
19 |
7.4 |
|
Working Status |
|
|
|
|
| Missing |
33 |
12.6 |
16 |
6.3 |
| Not Working |
72 |
27.6 |
81 |
31.6 |
| Working full/part time |
156 |
59.8 |
159 |
62.1 |
|
Cancer Type |
|
|
|
|
| Bladder |
8 |
3.1 |
5 |
2.0 |
| Breast |
70 |
26.8 |
81 |
31.6 |
| Colorectal |
21 |
8.0 |
28 |
10.9 |
| Gastrointestinal, not colorectal |
47 |
18 |
47 |
18.3 |
| Head and Neck |
15 |
5.7 |
12 |
4.7 |
| Leukemia/lymphoma/myeloma |
41 |
15.7 |
30 |
11.8 |
| Prostate |
48 |
18.4 |
49 |
19.1 |
| Other |
21 |
8 |
16 |
6.3 |
| Missing |
8 |
3.1 |
5 |
1.9 |
|
Stage |
|
|
|
|
| 0 |
8 |
3.1 |
2 |
0.8 |
| 1 |
44 |
16.9 |
39 |
15.2 |
| 2 |
60 |
23.0 |
67 |
26.2 |
| 3 |
38 |
14.6 |
56 |
21.9 |
| 4 |
73 |
28.0 |
65 |
25.4 |
| N/A |
3 |
1.1 |
0 |
0 |
| Missing |
35 |
13.4 |
27 |
10.5 |
| SDS-15 (T2) mean (SD) | 27.0 (8.12) | 26.6 (7.73) | ||
SD, standard deviation.